Talkspace, Inc. (NASDAQ: TALK) Stock Competitors & Peer Comparison
See TALK's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TALK and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TALK | $5.25 | +0.00% | 870.6M | 774.34 | $0.01 | N/A |
| HCA | $454.88 | -0.86% | 98.5B | 15.70 | $28.96 | +0.67% |
| THC | $266.39 | -0.32% | 21.4B | 15.45 | $17.24 | N/A |
| EHC | $121.71 | -4.82% | 12B | 20.84 | $5.84 | +0.64% |
| DVA | $187.00 | -0.17% | 11.9B | 14.62 | $12.80 | N/A |
| FMS | $21.94 | -1.04% | 11.7B | 8.24 | $2.66 | +3.94% |
| UHS | $182.29 | -1.52% | 10.7B | 8.09 | $22.54 | +0.44% |
| ENSG | $173.05 | -2.03% | 10.1B | 25.07 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $45.85 | -2.26% | 7.3B | 24.25 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
TALK vs HCA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, HCA has a market cap of 98.5B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while HCA trades at $454.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas HCA's P/E ratio is 15.70. In terms of profitability, TALK's ROE is +0.00%, compared to HCA's ROE of -1.13%. Regarding short-term risk, TALK is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
TALK vs THC Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, THC has a market cap of 21.4B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while THC trades at $266.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas THC's P/E ratio is 15.45. In terms of profitability, TALK's ROE is +0.00%, compared to THC's ROE of +0.51%. Regarding short-term risk, TALK is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for TALK.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
TALK vs EHC Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, EHC has a market cap of 12B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while EHC trades at $121.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas EHC's P/E ratio is 20.84. In terms of profitability, TALK's ROE is +0.00%, compared to EHC's ROE of +0.25%. Regarding short-term risk, TALK is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for TALK.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
TALK vs DVA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, DVA has a market cap of 11.9B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while DVA trades at $187.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas DVA's P/E ratio is 14.62. In terms of profitability, TALK's ROE is +0.00%, compared to DVA's ROE of -1.24%. Regarding short-term risk, TALK is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check DVA's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
TALK vs FMS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, FMS has a market cap of 11.7B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while FMS trades at $21.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas FMS's P/E ratio is 8.24. In terms of profitability, TALK's ROE is +0.00%, compared to FMS's ROE of +0.07%. Regarding short-term risk, TALK is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check FMS's competition here
Universal Health Services, Inc. (NYSE: UHS)
TALK vs UHS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, UHS has a market cap of 10.7B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while UHS trades at $182.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas UHS's P/E ratio is 8.09. In terms of profitability, TALK's ROE is +0.00%, compared to UHS's ROE of +0.21%. Regarding short-term risk, TALK is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
TALK vs ENSG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ENSG trades at $173.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ENSG's P/E ratio is 25.07. In terms of profitability, TALK's ROE is +0.00%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, TALK is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
TALK vs OSH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas OSH's P/E ratio is -17.65. In terms of profitability, TALK's ROE is +0.00%, compared to OSH's ROE of +4.64%. Regarding short-term risk, TALK is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for TALK.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
TALK vs PACS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, PACS has a market cap of 7.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while PACS trades at $45.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas PACS's P/E ratio is 24.25. In terms of profitability, TALK's ROE is +0.00%, compared to PACS's ROE of +0.27%. Regarding short-term risk, TALK is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
TALK vs CHE Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CHE trades at $508.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CHE's P/E ratio is 23.54. In terms of profitability, TALK's ROE is +0.00%, compared to CHE's ROE of +0.29%. Regarding short-term risk, TALK is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
TALK vs HIMS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, HIMS has a market cap of 6.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while HIMS trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas HIMS's P/E ratio is -43.96. In terms of profitability, TALK's ROE is +0.00%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, TALK is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
TALK vs LHCG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas LHCG's P/E ratio is 82.83. In terms of profitability, TALK's ROE is +0.00%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, TALK is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for TALK.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
TALK vs CON Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CON has a market cap of 4.9B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CON trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CON's P/E ratio is 24.01. In terms of profitability, TALK's ROE is +0.00%, compared to CON's ROE of +0.47%. Regarding short-term risk, TALK is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
TALK vs OPCH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while OPCH trades at $31.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas OPCH's P/E ratio is 18.14. In terms of profitability, TALK's ROE is +0.00%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, TALK is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check OPCH's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
TALK vs LFST Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, LFST has a market cap of 4.5B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while LFST trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas LFST's P/E ratio is 88.65. In terms of profitability, TALK's ROE is +0.00%, compared to LFST's ROE of +0.03%. Regarding short-term risk, TALK is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for TALK.Check LFST's competition here
National HealthCare Corporation (AMEX: NHC)
TALK vs NHC Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, NHC has a market cap of 3.8B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while NHC trades at $239.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas NHC's P/E ratio is 30.55. In terms of profitability, TALK's ROE is +0.00%, compared to NHC's ROE of +0.13%. Regarding short-term risk, TALK is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for TALK.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
TALK vs AMED Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AMED's P/E ratio is 39.30. In terms of profitability, TALK's ROE is +0.00%, compared to AMED's ROE of +0.04%. Regarding short-term risk, TALK is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for TALK.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
TALK vs ACHC Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ACHC has a market cap of 2.8B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ACHC trades at $30.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ACHC's P/E ratio is 15.17. In terms of profitability, TALK's ROE is +0.00%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, TALK is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
TALK vs AVAH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AVAH trades at $12.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AVAH's P/E ratio is 18.29. In terms of profitability, TALK's ROE is +0.00%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, TALK is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
TALK vs GRDN Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, GRDN has a market cap of 2.5B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while GRDN trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas GRDN's P/E ratio is 35.19. In terms of profitability, TALK's ROE is +0.00%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, TALK is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for TALK.Check GRDN's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
TALK vs BKD Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, BKD has a market cap of 2.4B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while BKD trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas BKD's P/E ratio is -17.00. In terms of profitability, TALK's ROE is +0.00%, compared to BKD's ROE of +4.06%. Regarding short-term risk, TALK is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for TALK.Check BKD's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
TALK vs MD Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while MD trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas MD's P/E ratio is 12.19. In terms of profitability, TALK's ROE is +0.00%, compared to MD's ROE of +0.20%. Regarding short-term risk, TALK is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for TALK.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
TALK vs ADUS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ADUS trades at $115.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ADUS's P/E ratio is 17.24. In terms of profitability, TALK's ROE is +0.00%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, TALK is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
TALK vs SEM Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SEM's P/E ratio is 15.43. In terms of profitability, TALK's ROE is +0.00%, compared to SEM's ROE of +0.08%. Regarding short-term risk, TALK is less volatile compared to SEM. This indicates lower risk in terms of short-term price fluctuations for TALK.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
TALK vs SGRY Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SGRY trades at $14.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SGRY's P/E ratio is 37.72. In terms of profitability, TALK's ROE is +0.00%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, TALK is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for TALK.Check SGRY's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
TALK vs ASTH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ASTH trades at $36.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ASTH's P/E ratio is 44.46. In terms of profitability, TALK's ROE is +0.00%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, TALK is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
TALK vs AMEH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AMEH's P/E ratio is 39.25. In terms of profitability, TALK's ROE is +0.00%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, TALK is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
TALK vs ARDT Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ARDT trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ARDT's P/E ratio is 9.43. In terms of profitability, TALK's ROE is +0.00%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, TALK is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ARDT's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
TALK vs SNDA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SNDA trades at $34.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SNDA's P/E ratio is -5.50. In terms of profitability, TALK's ROE is +0.00%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, TALK is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check SNDA's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
TALK vs AMN Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AMN has a market cap of 1.6B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AMN trades at $40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AMN's P/E ratio is 13.44. In terms of profitability, TALK's ROE is +0.00%, compared to AMN's ROE of +0.15%. Regarding short-term risk, TALK is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AMN's competition here
Agilon Health, Inc. (NYSE: AGL)
TALK vs AGL Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AGL trades at $88.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AGL's P/E ratio is -5.76. In terms of profitability, TALK's ROE is +0.00%, compared to AGL's ROE of -1.19%. Regarding short-term risk, TALK is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
TALK vs HCSG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while HCSG trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas HCSG's P/E ratio is 16.89. In terms of profitability, TALK's ROE is +0.00%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, TALK is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for TALK.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
TALK vs PNTG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while PNTG trades at $40.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas PNTG's P/E ratio is 30.80. In terms of profitability, TALK's ROE is +0.00%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, TALK is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for TALK.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
TALK vs NUTX Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while NUTX trades at $191.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas NUTX's P/E ratio is 7.58. In terms of profitability, TALK's ROE is +0.00%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, TALK is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for TALK.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
TALK vs USPH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while USPH trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas USPH's P/E ratio is 33.08. In terms of profitability, TALK's ROE is +0.00%, compared to USPH's ROE of -0.01%. Regarding short-term risk, TALK is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
TALK vs BKDT Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas BKDT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, TALK is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for TALK.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
TALK vs INNV Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while INNV trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas INNV's P/E ratio is -444.00. In terms of profitability, TALK's ROE is +0.00%, compared to INNV's ROE of -0.01%. Regarding short-term risk, TALK is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for TALK.Check INNV's competition here
Enhabit, Inc. (NYSE: EHAB)
TALK vs EHAB Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas EHAB's P/E ratio is -197.14. In terms of profitability, TALK's ROE is +0.00%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, TALK is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for TALK.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
TALK vs STLN Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while STLN trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas STLN's P/E ratio is -21.13. In terms of profitability, TALK's ROE is +0.00%, compared to STLN's ROE of +2.10%. Regarding short-term risk, TALK is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for TALK.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
TALK vs GMRS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, GMRS has a market cap of 540.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while GMRS trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas GMRS's P/E ratio is -4.93. In terms of profitability, TALK's ROE is +0.00%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, TALK is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
TALK vs TOI Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TOI's P/E ratio is -14.25. In terms of profitability, TALK's ROE is +0.00%, compared to TOI's ROE of +2.10%. Regarding short-term risk, TALK is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for TALK.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
TALK vs MCTA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas MCTA's P/E ratio is 419.36. In terms of profitability, TALK's ROE is +0.00%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, TALK is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for TALK.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
TALK vs SRTA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SRTA has a market cap of 401.6M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SRTA trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SRTA's P/E ratio is -21.40. In terms of profitability, TALK's ROE is +0.00%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, TALK is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
TALK vs AUNA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AUNA has a market cap of 399.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AUNA trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AUNA's P/E ratio is 4.86. In terms of profitability, TALK's ROE is +0.00%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, TALK is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
TALK vs CYH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CYH has a market cap of 389.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CYH trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CYH's P/E ratio is 3.79. In terms of profitability, TALK's ROE is +0.00%, compared to CYH's ROE of +0.21%. Regarding short-term risk, TALK is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CYH's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
TALK vs VMD Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, VMD has a market cap of 365.3M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while VMD trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas VMD's P/E ratio is 26.64. In terms of profitability, TALK's ROE is +0.00%, compared to VMD's ROE of +0.10%. Regarding short-term risk, TALK is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for TALK.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
TALK vs CSU Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CSU's P/E ratio is 0.67. In terms of profitability, TALK's ROE is +0.00%, compared to CSU's ROE of -0.33%. Regarding short-term risk, TALK is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
TALK vs JYNT Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, JYNT has a market cap of 103.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while JYNT trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas JYNT's P/E ratio is 48.87. In terms of profitability, TALK's ROE is +0.00%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, TALK is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for TALK.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
TALK vs FVE Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas FVE's P/E ratio is -5.64. In terms of profitability, TALK's ROE is +0.00%, compared to FVE's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for TALK.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
TALK vs KDLYW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas KDLYW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, TALK is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check KDLYW's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
TALK vs AIRS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AIRS has a market cap of 89.8M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AIRS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AIRS's P/E ratio is -41.50. In terms of profitability, TALK's ROE is +0.00%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, TALK is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AIRS's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
TALK vs PARK Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, PARK has a market cap of 89.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while PARK trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas PARK's P/E ratio is 25.49. In terms of profitability, TALK's ROE is +0.00%, compared to PARK's ROE of -0.18%. Regarding short-term risk, TALK is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for TALK.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
TALK vs BTMD Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, BTMD has a market cap of 47.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while BTMD trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas BTMD's P/E ratio is 9.73. In terms of profitability, TALK's ROE is +0.00%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, TALK is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for TALK.Check BTMD's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
TALK vs EUDA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, EUDA has a market cap of 46.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while EUDA trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas EUDA's P/E ratio is -13.46. In terms of profitability, TALK's ROE is +0.00%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, TALK is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check EUDA's competition here
AlerisLife Inc. (NASDAQ: ALR)
TALK vs ALR Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ALR's P/E ratio is -1.11. In terms of profitability, TALK's ROE is +0.00%, compared to ALR's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ALR's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
TALK vs CCEL Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CCEL has a market cap of 36.8M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CCEL trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CCEL's P/E ratio is -19.87. In terms of profitability, TALK's ROE is +0.00%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, TALK is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
TALK vs IMAC Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas IMAC's P/E ratio is -2.27. In terms of profitability, TALK's ROE is +0.00%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, TALK is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for TALK.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
TALK vs DCGO Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, DCGO has a market cap of 25.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while DCGO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas DCGO's P/E ratio is -0.14. In terms of profitability, TALK's ROE is +0.00%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, TALK is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for TALK.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
TALK vs CANO-WT Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, TALK is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CANO-WT's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
TALK vs PIIIW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, PIIIW has a market cap of 19.1M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas PIIIW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, TALK is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
TALK vs AIH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AIH's P/E ratio is -2.78. In terms of profitability, TALK's ROE is +0.00%, compared to AIH's ROE of +1.16%. Regarding short-term risk, TALK is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
TALK vs PIII Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, PIII has a market cap of 12.9M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while PIII trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas PIII's P/E ratio is -0.12. In terms of profitability, TALK's ROE is +0.00%, compared to PIII's ROE of +1.61%. Regarding short-term risk, TALK is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for TALK.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
TALK vs CANO Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CANO's P/E ratio is -0.01. In terms of profitability, TALK's ROE is +0.00%, compared to CANO's ROE of -1.49%. Regarding short-term risk, TALK is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
TALK vs FPCG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas FPCG's P/E ratio is 0.09. In terms of profitability, TALK's ROE is +0.00%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, TALK is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for TALK.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
TALK vs FTRP Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas FTRP's P/E ratio is -1.22. In terms of profitability, TALK's ROE is +0.00%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, TALK is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for TALK.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
TALK vs AMS Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AMS has a market cap of 8.3M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AMS trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AMS's P/E ratio is -4.93. In terms of profitability, TALK's ROE is +0.00%, compared to AMS's ROE of -0.07%. Regarding short-term risk, TALK is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
TALK vs BMGL Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, BMGL has a market cap of 6.4M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while BMGL trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas BMGL's P/E ratio is -0.81. In terms of profitability, TALK's ROE is +0.00%, compared to BMGL's ROE of -1.64%. Regarding short-term risk, TALK is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for TALK.Check BMGL's competition here
ModivCare Inc. (NASDAQ: MODV)
TALK vs MODV Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas MODV's P/E ratio is -0.06. In terms of profitability, TALK's ROE is +0.00%, compared to MODV's ROE of +0.88%. Regarding short-term risk, TALK is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for TALK.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
TALK vs GBNH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas GBNH's P/E ratio is -0.06. In terms of profitability, TALK's ROE is +0.00%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, TALK is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
TALK vs RHE-PA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, TALK's ROE is +0.00%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, TALK is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
TALK vs RHE Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas RHE's P/E ratio is -1.79. In terms of profitability, TALK's ROE is +0.00%, compared to RHE's ROE of -1.31%. Regarding short-term risk, TALK is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for TALK.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
TALK vs TOIIW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, TALK's ROE is +0.00%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, TALK is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for TALK.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
TALK vs AIDX Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AIDX has a market cap of 3.3M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AIDX trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AIDX's P/E ratio is -0.36. In terms of profitability, TALK's ROE is +0.00%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, TALK is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AIDX's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
TALK vs STLNW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, STLNW has a market cap of 2.8M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while STLNW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas STLNW's P/E ratio is -0.09. In terms of profitability, TALK's ROE is +0.00%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, TALK is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
TALK vs IMACW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas IMACW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, TALK is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check IMACW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
TALK vs EUDAW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, EUDAW has a market cap of 971.7K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, TALK's ROE is +0.00%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, TALK is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check EUDAW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
TALK vs EDVA Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, EDVA has a market cap of 871.5K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while EDVA trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas EDVA's P/E ratio is -0.01. In terms of profitability, TALK's ROE is +0.00%, compared to EDVA's ROE of N/A. Regarding short-term risk, TALK is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for TALK.Check EDVA's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
TALK vs CCM Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, CCM has a market cap of 516.7K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while CCM trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas CCM's P/E ratio is -1.20. In terms of profitability, TALK's ROE is +0.00%, compared to CCM's ROE of +0.05%. Regarding short-term risk, TALK is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for TALK.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
TALK vs NIVFW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, NIVFW has a market cap of 35K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas NIVFW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, TALK is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for TALK.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
TALK vs TALKW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TALKW's P/E ratio is 0.00. In terms of profitability, TALK's ROE is +0.00%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, TALK is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
TALK vs MNDR Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, MNDR has a market cap of 22.5K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while MNDR trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas MNDR's P/E ratio is -0.06. In terms of profitability, TALK's ROE is +0.00%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for TALK.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
TALK vs TNONW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TNONW has a market cap of 5.1K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TNONW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TNONW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to TNONW's ROE of N/A. Regarding short-term risk, TALK is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
TALK vs NIVF Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, NIVF has a market cap of 4.4K. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while NIVF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas NIVF's P/E ratio is 0.14. In terms of profitability, TALK's ROE is +0.00%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, TALK is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for TALK.Check NIVF's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
TALK vs TVTY Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TVTY's P/E ratio is 19.06. In terms of profitability, TALK's ROE is +0.00%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, TALK is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for TALK.Check TVTY's competition here
Kindred Healthcare, Inc. (NYSE: KND)
TALK vs KND Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, KND has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas KND's P/E ratio is -1.14. In terms of profitability, TALK's ROE is +0.00%, compared to KND's ROE of -0.53%. Regarding short-term risk, TALK is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for TALK.Check KND's competition here
Hanger, Inc. (NYSE: HNGR)
TALK vs HNGR Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas HNGR's P/E ratio is 19.71. In terms of profitability, TALK's ROE is +0.00%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, TALK is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for TALK.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
TALK vs DVCR Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas DVCR's P/E ratio is 28.34. In terms of profitability, TALK's ROE is +0.00%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for TALK.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
TALK vs AFAM Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas AFAM's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, TALK is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for TALK.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
TALK vs TLMD Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TLMD's P/E ratio is -1.60. In terms of profitability, TALK's ROE is +0.00%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for TALK.Check TLMD's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
TALK vs SLHGP Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, TALK's ROE is +0.00%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, TALK is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for TALK.Check SLHGP's competition here
DocGo Inc. (NASDAQ: DCGOW)
TALK vs DCGOW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas DCGOW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, TALK is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check DCGOW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
TALK vs SLHG Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas SLHG's P/E ratio is -1.48. In terms of profitability, TALK's ROE is +0.00%, compared to SLHG's ROE of N/A. Regarding short-term risk, TALK is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for TALK.Check SLHG's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
TALK vs TLMDW Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas TLMDW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for TALK.Check TLMDW's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
TALK vs ATIP-WT Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.00%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, TALK is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for TALK.Check ATIP-WT's competition here
New Frontier Health Corporation (NYSE: NFH)
TALK vs NFH Comparison October 2026
Talkspace, Inc. (NASDAQ: TALK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 870.6M. In comparison, NFH has a market cap of 0. Regarding current trading prices, TALK is priced at $5.25 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 774.34, whereas NFH's P/E ratio is -19.75. In terms of profitability, TALK's ROE is +0.00%, compared to NFH's ROE of -0.06%. Regarding short-term risk, TALK is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for TALK.Check NFH's competition here